JP5552053B2 - ファージφＭＲＵポリヌクレオチドおよびポリペプチドならびにその使用 - Google Patents

ファージφＭＲＵポリヌクレオチドおよびポリペプチドならびにその使用 Download PDF

Info

Publication number
JP5552053B2
JP5552053B2 JP2010526840A JP2010526840A JP5552053B2 JP 5552053 B2 JP5552053 B2 JP 5552053B2 JP 2010526840 A JP2010526840 A JP 2010526840A JP 2010526840 A JP2010526840 A JP 2010526840A JP 5552053 B2 JP5552053 B2 JP 5552053B2
Authority
JP
Japan
Prior art keywords
polypeptide
phage
sequence
acid sequence
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010526840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539927A5 (enExample
JP2010539927A (ja
Inventor
ハインツ オルターマン，エリック
トレバー アトウッド，グレアム
クリスティーヌ リーヒ，シネイド
ジョン ケリー，ウィリアム
スター ロニマス，ロバート
ドン リ
ツァンハオ コン
ローズ スコフィールド，リンレイ
デイ，デブジット
メアリー トゥーチル，キャサリン
サン，キャリー
ダイアン ムーン，クリスティーナ
ヘンドリクス ジャンセン，ペトルス
Original Assignee
パストラル グリーンハウス ガス リサーチ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by パストラル グリーンハウス ガス リサーチ リミテッド filed Critical パストラル グリーンハウス ガス リサーチ リミテッド
Publication of JP2010539927A publication Critical patent/JP2010539927A/ja
Publication of JP2010539927A5 publication Critical patent/JP2010539927A5/ja
Application granted granted Critical
Publication of JP5552053B2 publication Critical patent/JP5552053B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22—Methane [CH4], e.g. from rice paddies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
JP2010526840A 2007-09-25 2008-09-25 ファージφＭＲＵポリヌクレオチドおよびポリペプチドならびにその使用 Expired - Fee Related JP5552053B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US97510407P 2007-09-25 2007-09-25
US60/975,104 2007-09-25
US98984007P 2007-11-22 2007-11-22
US98984107P 2007-11-22 2007-11-22
US60/989,841 2007-11-22
US60/989,840 2007-11-22
PCT/NZ2008/000248 WO2009041831A1 (en) 2007-09-25 2008-09-25 PHAGE ϕ-MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2010539927A JP2010539927A (ja) 2010-12-24
JP2010539927A5 JP2010539927A5 (enExample) 2011-11-17
JP5552053B2 true JP5552053B2 (ja) 2014-07-16

Family

ID=40511642

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2010526839A Expired - Fee Related JP5558356B2 (ja) 2007-09-25 2008-09-25 微生物細胞のための細胞透過性ペプチドおよびポリペプチド
JP2010526840A Expired - Fee Related JP5552053B2 (ja) 2007-09-25 2008-09-25 ファージφＭＲＵポリヌクレオチドおよびポリペプチドならびにその使用
JP2010526841A Active JP6067209B2 (ja) 2007-09-25 2008-09-25 微生物細胞抑制のためのワクチンおよびワクチン構成成分
JP2014139171A Pending JP2015042166A (ja) 2007-09-25 2014-07-04 微生物細胞抑制のためのワクチンおよびワクチン構成成分
JP2016197575A Pending JP2017046704A (ja) 2007-09-25 2016-10-05 微生物細胞抑制のためのワクチンおよびワクチン構成成分

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010526839A Expired - Fee Related JP5558356B2 (ja) 2007-09-25 2008-09-25 微生物細胞のための細胞透過性ペプチドおよびポリペプチド

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2010526841A Active JP6067209B2 (ja) 2007-09-25 2008-09-25 微生物細胞抑制のためのワクチンおよびワクチン構成成分
JP2014139171A Pending JP2015042166A (ja) 2007-09-25 2014-07-04 微生物細胞抑制のためのワクチンおよびワクチン構成成分
JP2016197575A Pending JP2017046704A (ja) 2007-09-25 2016-10-05 微生物細胞抑制のためのワクチンおよびワクチン構成成分

Country Status (17)

Country Link
US (7) US8592556B2 (enExample)
EP (5) EP3327030B1 (enExample)
JP (5) JP5558356B2 (enExample)
CN (4) CN101918431B (enExample)
AR (3) AR068553A1 (enExample)
AU (4) AU2008304018A1 (enExample)
BR (5) BR122021010729B1 (enExample)
CA (3) CA2700164C (enExample)
CL (3) CL2008002860A1 (enExample)
DK (3) DK3327030T3 (enExample)
ES (3) ES2895908T3 (enExample)
MX (3) MX2010003321A (enExample)
NZ (1) NZ745324A (enExample)
RU (1) RU2528854C2 (enExample)
UY (3) UY31360A1 (enExample)
WO (3) WO2009041830A2 (enExample)
ZA (1) ZA201001933B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ745324A (en) * 2007-09-25 2023-02-24 Pastoral Greenhouse Gas Res Ltd Vaccines and vaccine components for inhibition of microbial cells
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
AU2010264659B2 (en) 2009-06-26 2016-08-04 Lysando Aktiengesellschaft Antimicrobial agents
SI2445515T1 (sl) * 2009-06-26 2016-08-31 Lysando Ag Antimikrobna sredstva
AU2010287069B2 (en) 2009-08-27 2016-07-07 Lucidome Bio Limited Complete genome sequence of the methanogen Methanobrevibacter ruminantium
WO2011134998A1 (en) * 2010-04-27 2011-11-03 Lysando Holding Ag Method of reducing biofilms
EP3736282B1 (en) * 2012-09-19 2023-06-21 Gemvax & Kael Co., Ltd. Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
EP4234696A3 (en) * 2012-12-12 2023-09-06 The Broad Institute Inc. Crispr-cas component systems, methods and compositions for sequence manipulation
KR102271291B1 (ko) 2013-03-15 2021-07-02 더 제너럴 하스피탈 코포레이션 특정 게놈 좌위에 대한 유전적 및 후성적 조절 단백질의 rna-안내 표적화
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US10011850B2 (en) 2013-06-21 2018-07-03 The General Hospital Corporation Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
EP3066201B1 (en) 2013-11-07 2018-03-07 Editas Medicine, Inc. Crispr-related methods and compositions with governing grnas
DK3597740T3 (da) * 2014-11-06 2022-06-20 Dupont Us Holding Llc Peptidmedieret indføring af rna-styret endonuklease i celler
CN104789675A (zh) * 2015-04-15 2015-07-22 江苏师范大学 一种检测荷斯坦奶牛瘤胃微生物的方法
CN108026566A (zh) * 2015-05-04 2018-05-11 特拉维夫大学拉莫特有限公司 用于使dna片段化的方法和试剂盒
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
DK3484996T3 (da) * 2016-07-14 2020-12-07 Basf Se Fermenteringsmedium, der omfatter et chelateringsmiddel
CA3048863A1 (en) * 2016-12-29 2018-07-05 Illumina, Inc. Analysis system for orthogonal access to and tagging of biomolecules in cellular compartments
WO2018126499A1 (zh) * 2017-01-05 2018-07-12 深圳迈瑞生物医疗电子股份有限公司 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物
US10745439B2 (en) * 2017-03-20 2020-08-18 Regents Of The University Of Minnesota Kinase substrates and methods of use thereof
US20190233816A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
EP3592140A1 (en) * 2018-03-19 2020-01-15 Regeneron Pharmaceuticals, Inc. Transcription modulation in animals using crispr/cas systems
WO2020102603A1 (en) 2018-11-14 2020-05-22 Rubryc Therapeutics, Inc. Engineered cd25 polypeptides and uses thereof
EP3880227A4 (en) 2018-11-14 2022-11-09 RubrYc Therapeutics, Inc. ANTI-CD25 ANTIBODIES
CN109627301B (zh) * 2019-02-18 2022-08-05 浙江新银象生物工程有限公司 Nisin固体稳定剂开发及应用
BR112022018599A2 (pt) * 2020-03-19 2022-12-20 Micreos Human Health Bv Uma proteína de interesse estabilizada
US20230072496A1 (en) * 2020-04-10 2023-03-09 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
EP4037666B1 (en) 2020-12-08 2024-05-01 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals
CN112961217B (zh) * 2021-03-19 2022-11-08 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN113121705B (zh) * 2021-04-19 2023-03-24 成都英普博集生物科技有限公司 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用
US20240009291A1 (en) * 2022-07-11 2024-01-11 Arkea Bio Corp. Compositions and methods for reducing methane emissions in ruminant populations
CN115417927A (zh) * 2022-09-08 2022-12-02 南京松天盛科生物科技有限公司 小鼠腹水致敏物及其应用
WO2024097397A1 (en) * 2022-11-03 2024-05-10 Helix Nanotechnologies, Inc. Ruminal and methanogen vaccines and uses thereof
CN115938486B (zh) * 2022-12-06 2023-11-10 内蒙古农业大学 基于图神经网络的抗菌性乳酸菌株筛选方法
WO2025219570A1 (en) 2024-04-17 2025-10-23 Johannes Kepler Universität Linz Composition for inhibiting protein translocation and methods using the same
WO2025233675A1 (en) * 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US159861A (en) * 1875-02-16 Improvement in brooms
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
WO1984004249A2 (fr) * 1983-05-03 1984-11-08 Ssm Int Chem Co Ltd Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
JPH05219927A (ja) * 1992-02-14 1993-08-31 Gumma Pref Gov 飼料の混合装置及び混合飼料の製造方法
JP3651915B2 (ja) * 1993-06-30 2005-05-25 財団法人神奈川科学技術アカデミー シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター
PT724454E (pt) * 1993-10-19 2004-08-31 Commw Scient Ind Res Org Metodo para melhorar a utilizacao de nutrientes pelos animais ruminantes ou semelhantes a ruminantes
EP0730663B1 (en) 1993-10-26 2003-09-24 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
DK0739198T3 (da) 1994-01-20 2004-01-26 Agres Ltd Anordning til indgivelse af gavnlige materialer til drøvtyggere
NZ278977A (en) 1994-01-20 1997-03-24 Pastoral Agric Res Inst Nz Ltd Sustained release bolus for ruminants
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
AUPN353695A0 (en) 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
WO1998007830A2 (en) * 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US5985907A (en) * 1998-08-12 1999-11-16 Health Research, Inc. Method for inhibiting growth of methanogens
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
WO2003038109A2 (en) 2001-09-18 2003-05-08 The Board Of Regents Of The University Of Nebraska Method for the inhibition of methanogenesis
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
WO2003076575A2 (en) * 2002-03-04 2003-09-18 Fidelity Systems, Inc., Et Al. The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
SE523209C2 (sv) * 2002-05-14 2004-04-06 Akzo Nobel Nv Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur
WO2006102350A1 (en) 2005-03-23 2006-09-28 Washington University In St. Louis The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
NZ745324A (en) * 2007-09-25 2023-02-24 Pastoral Greenhouse Gas Res Ltd Vaccines and vaccine components for inhibition of microbial cells
CN101434924A (zh) * 2008-12-17 2009-05-20 中南大学 一种分离严格厌氧产甲烷古菌的方法
AU2010287069B2 (en) * 2009-08-27 2016-07-07 Lucidome Bio Limited Complete genome sequence of the methanogen Methanobrevibacter ruminantium
CN101864362B (zh) * 2010-05-19 2012-05-09 江苏加德绿色能源有限公司 一种复合微生物菌剂及其应用
DE102011119230B4 (de) * 2011-11-23 2013-07-11 Audi Ag Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte
EP2935364A2 (en) * 2012-12-21 2015-10-28 Danisco US Inc. Production of isoprene, isoprenoid, and isoprenoid precursors using an alternative lower mevalonate pathway

Also Published As

Publication number Publication date
US8592556B2 (en) 2013-11-26
US20170342112A1 (en) 2017-11-30
CA2700164A1 (en) 2009-04-02
US20100221185A1 (en) 2010-09-02
MX2010003328A (es) 2010-08-16
CL2008002860A1 (es) 2009-06-05
ZA201001933B (en) 2013-10-30
BR122021010729B1 (pt) 2022-02-15
NZ780936A (en) 2024-08-30
CA2700129A1 (en) 2009-04-02
MX2010003319A (es) 2010-09-10
US10590170B2 (en) 2020-03-17
EP2203470A4 (en) 2011-04-13
CN101932595B (zh) 2016-02-10
EP2203467A4 (en) 2011-04-13
UY31361A1 (es) 2009-04-30
WO2009041832A3 (en) 2009-06-11
EP3327030B1 (en) 2021-07-21
US20100209999A1 (en) 2010-08-19
CA2700162A1 (en) 2009-04-02
EP3936516A1 (en) 2022-01-12
JP2010539926A (ja) 2010-12-24
US11926647B2 (en) 2024-03-12
AU2008305846A1 (en) 2009-04-02
NZ745324A (en) 2023-02-24
AU2014210649A1 (en) 2014-09-04
RU2010116163A (ru) 2011-11-10
AU2014210649B2 (en) 2016-09-08
US20100209998A1 (en) 2010-08-19
DK2203466T3 (en) 2016-07-25
BR122020023381B1 (pt) 2021-09-08
US10995120B2 (en) 2021-05-04
EP2203467B1 (en) 2016-12-14
EP2203470A2 (en) 2010-07-07
CN101918431B (zh) 2014-10-08
MX340736B (es) 2016-07-22
AR068552A1 (es) 2009-11-18
DK3327030T3 (da) 2021-10-04
CL2008002859A1 (es) 2009-03-06
CN102015755A (zh) 2011-04-13
WO2009041832A2 (en) 2009-04-02
CA2700162C (en) 2018-08-14
UY31360A1 (es) 2009-04-30
WO2009041831A9 (en) 2009-11-05
JP6067209B2 (ja) 2017-01-25
JP5558356B2 (ja) 2014-07-23
AU2008304018A1 (en) 2009-04-02
JP2010539928A (ja) 2010-12-24
JP2015042166A (ja) 2015-03-05
US9296789B2 (en) 2016-03-29
WO2009041832A9 (en) 2009-10-22
UY31359A1 (es) 2009-04-30
WO2009041830A9 (en) 2009-08-27
RU2528854C2 (ru) 2014-09-20
WO2009041831A1 (en) 2009-04-02
ES2625144T3 (es) 2017-07-18
BRPI0817312A2 (pt) 2015-03-17
EP2203466A4 (en) 2011-04-13
BR122021010737B1 (pt) 2021-09-21
CN101932595A (zh) 2010-12-29
CN107129524A (zh) 2017-09-05
ES2895908T3 (es) 2022-02-23
AR068551A1 (es) 2009-11-18
AU2008304019A1 (en) 2009-04-02
BRPI0817299A8 (pt) 2019-01-29
AR068553A1 (es) 2009-11-18
WO2009041830A3 (en) 2009-07-02
DK2203467T3 (en) 2017-03-27
CN101918431A (zh) 2010-12-15
CN107129524B (zh) 2023-11-21
JP2010539927A (ja) 2010-12-24
US8586709B2 (en) 2013-11-19
BRPI0817299A2 (pt) 2015-06-16
MX2010003321A (es) 2010-08-03
US20200325180A1 (en) 2020-10-15
CA2700164C (en) 2018-05-29
US20140220636A1 (en) 2014-08-07
EP2203466B1 (en) 2016-04-06
ES2587595T3 (es) 2016-10-25
EP3327030A1 (en) 2018-05-30
EP2203466A2 (en) 2010-07-07
BRPI0817312B1 (pt) 2018-05-29
JP2017046704A (ja) 2017-03-09
US20210332087A1 (en) 2021-10-28
CL2008002861A1 (es) 2009-03-06
CA2700129C (en) 2021-07-20
WO2009041830A2 (en) 2009-04-02
EP2203467A1 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
JP5552053B2 (ja) ファージφＭＲＵポリヌクレオチドおよびポリペプチドならびにその使用
RU2520738C2 (ru) ПОЛИНУКЛЕОТИДЫ И ПОЛИПЕПТИДЫ ФАГА φ-mru, И ИХ ПРИМЕНЕНИЕ
AU2014210647A1 (en) Phage phimru polynucleotides and polypeptides and uses thereof
Class et al. Patent application title: PHAGE &phgr; MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
AU2014213519B2 (en) Vaccines and vaccine components for inhibition of microbial cells
AU2019203617A1 (en) Vaccines and vaccine components for inhibition of microbial cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110921

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130604

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130903

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130910

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131003

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131010

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140228

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140325

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140415

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140422

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140523

R150 Certificate of patent or registration of utility model

Ref document number: 5552053

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees